Dnyaneshwar D. Subhedar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dnyaneshwar D. Subhedar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Mubarak H. Shaikh
Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, 431004, India
15 shared publications- Bapurao Babruwan Shingate
Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University
13 shared publications Dhiman Sarkar
Combichem Bioresource Centre, National Chemical Laboratory, Pune 411 008, India
10 shared publicationsFiroz A. Kalam Khan
Department of Pharmaceutical Chemistry, Y. B. Chavan College of Pharmacy, Aurangabad 431 001, India
9 shared publications- Jaiprakash Navnath Sangshetti
Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Rauza Baugh, Aurangabad, MS, India
9 shared publications - Laxman Nawale
CombiChemBio Resource Centre, CSIR-National Chemical Laboratory, Pune, India
8 shared publications
Latest Publications
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 29 (3) , 226-237
[DBUH][HSO4]-catalyzed Solvent-free Synthesis of 1,5-benzodiazepine Derivatives: Bioevaluation and In silico Molecular Docking Study
: Here, we report the solvent-free one-pot multicomponent synthesis of 4- substituted-1,5-benzodiazepine derivatives from O-phenylenediamine, aromatic aldehydes, and dimedone using [DBUH][HSO4] as a catalyst in excellent yields. This process was carried out in search of a reusable, easily accessible, affordable, and efficient catalyst. 1,5- Benzodiazepines demonstrate a new family of good inhibitors with potent antimycobacterial properties. The most promising compounds in the present series are 4c, 4i, and 4l which showed excellent activity and inhibited the growth of both MTB H37Ra and M. bovis BCG strains with lower MICs. The most active compounds were further studied for their cytotoxicity against cell lines MCF-7, A549, HCT116, and THP-1 by MTT assays and the compounds were found to be non-toxic. The fact that none of these compounds work against either Gram-positive or Gram-negative bacteria suggests that they are only effective against MTB. The in silico docking of the molecules against mycobacterial enoyl reductase, InhA enzyme could provide well-clustered solutions and have given valuable insights into the thermodynamic elements governing the binding affinities. The findings of this investigation unmistakably point to the discovery of extremely specific and selective MTB inhibitors, which can now be investigated further in search of possible anti-tubercular drugs.
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Organic Chemistry
- Vol. 29 (3) , 226-237
[DBUH][HSO4]-catalyzed Solvent-free Synthesis of 1,5-benzodiazepine Derivatives: Bioevaluation and In silico Molecular Docking Study
: Here, we report the solvent-free one-pot multicomponent synthesis of 4- substituted-1,5-benzodiazepine derivatives from O-phenylenediamine, aromatic aldehydes, and dimedone using [DBUH][HSO4] as a catalyst in excellent yields. This process was carried out in search of a reusable, easily accessible, affordable, and efficient catalyst. 1,5- Benzodiazepines demonstrate a new family of good inhibitors with potent antimycobacterial properties. The most promising compounds in the present series are 4c, 4i, and 4l which showed excellent activity and inhibited the growth of both MTB H37Ra and M. bovis BCG strains with lower MICs. The most active compounds were further studied for their cytotoxicity against cell lines MCF-7, A549, HCT116, and THP-1 by MTT assays and the compounds were found to be non-toxic. The fact that none of these compounds work against either Gram-positive or Gram-negative bacteria suggests that they are only effective against MTB. The in silico docking of the molecules against mycobacterial enoyl reductase, InhA enzyme could provide well-clustered solutions and have given valuable insights into the thermodynamic elements governing the binding affinities. The findings of this investigation unmistakably point to the discovery of extremely specific and selective MTB inhibitors, which can now be investigated further in search of possible anti-tubercular drugs.
- 26 March 2018
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 18 (7) , 622-630
Facile and Solvent-free Domino Synthesis of New Quinolidinyl-2,4- thiazolidinones: Antifungal Activity and Molecular Docking
Objective: We have synthesized new quinolidinyl-thiazolidinones via Knoevenagel condensation- alkylation reaction, catalyzed by [Et3NH][HSO4]. The present approach offers several advantages such as higher yields, eco-friendly reaction condition and economic availability of the catalyst. Method: The newly synthesized compounds were evaluated for their in vitro antifungal activity against six fungal strains. Some of the synthesized conjugates displayed good to moderate antifungal activity. Conclusion: Again, the molecular docking study performed against the fungal sterol 14α-demethylase (CYP51) showed an excellent binding affinity towards the enzyme which could rationalize the promising antifungal activity portrayed by these derivatives and provides a platform for structure based drug design.
- 26 March 2018
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 18 (7) , 622-630
Facile and Solvent-free Domino Synthesis of New Quinolidinyl-2,4- thiazolidinones: Antifungal Activity and Molecular Docking
Objective: We have synthesized new quinolidinyl-thiazolidinones via Knoevenagel condensation- alkylation reaction, catalyzed by [Et3NH][HSO4]. The present approach offers several advantages such as higher yields, eco-friendly reaction condition and economic availability of the catalyst. Method: The newly synthesized compounds were evaluated for their in vitro antifungal activity against six fungal strains. Some of the synthesized conjugates displayed good to moderate antifungal activity. Conclusion: Again, the molecular docking study performed against the fungal sterol 14α-demethylase (CYP51) showed an excellent binding affinity towards the enzyme which could rationalize the promising antifungal activity portrayed by these derivatives and provides a platform for structure based drug design.
- 1 February 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (4) , 922-928
Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study
- 1 February 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (4) , 922-928
Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study
- 1 January 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 125, 385-399
Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation
- 1 January 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 125, 385-399
Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation
- 22 July 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 7 (9) , 1832-1848
Novel tetrazoloquinoline–thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking
A novel approach for the synthesis of a new 4-thiazolidinone scaffold was developed by a one-pot three-component cyclocondensation of various tetrazolo quinoline aldehydes 1a–f, acid hydrazide 2a–c, and thioglycolic acid 3 in the presence of [DBUH][OAc] as a catalyst in high yields. All the conjugates were screened for their antimycobacterial activity against MTB H37Ra and M. bovis BCG strains, with the MIC values ranging from 0.99–13.55 μmol mL−1 and 0.14–20.11 μmol mL−1, respectively. The 4-thiazolidinone-incorporated tetrazoloquinoline derivatives 4a, 4d, 4g, 4j, 4m, and 4p were highly potent against MTB H37Ra and M. bovis BCG strains. The most active compounds were also evaluated for their cytotoxicity against MCF-7, A549, and HCT 116 cell lines and were found to be non-cytotoxic. Further, molecular docking studies into the active site of the InhA enzyme revealed a similar binding mode to the native ligand in the crystal structure, thereby helping us to understand the ligand–protein binding interaction and establish a structural basis for the inhibition of mycobacterium tuberculosis. The results suggest that the tetrazoloquinoline–thiazolidinone conjugates 4a, 4d, 4g, 4j, 4m, and 4p are promising antitubercular agents.
- 22 July 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 7 (9) , 1832-1848
Novel tetrazoloquinoline–thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking
A novel approach for the synthesis of a new 4-thiazolidinone scaffold was developed by a one-pot three-component cyclocondensation of various tetrazolo quinoline aldehydes 1a–f, acid hydrazide 2a–c, and thioglycolic acid 3 in the presence of [DBUH][OAc] as a catalyst in high yields. All the conjugates were screened for their antimycobacterial activity against MTB H37Ra and M. bovis BCG strains, with the MIC values ranging from 0.99–13.55 μmol mL−1 and 0.14–20.11 μmol mL−1, respectively. The 4-thiazolidinone-incorporated tetrazoloquinoline derivatives 4a, 4d, 4g, 4j, 4m, and 4p were highly potent against MTB H37Ra and M. bovis BCG strains. The most active compounds were also evaluated for their cytotoxicity against MCF-7, A549, and HCT 116 cell lines and were found to be non-cytotoxic. Further, molecular docking studies into the active site of the InhA enzyme revealed a similar binding mode to the native ligand in the crystal structure, thereby helping us to understand the ligand–protein binding interaction and establish a structural basis for the inhibition of mycobacterium tuberculosis. The results suggest that the tetrazoloquinoline–thiazolidinone conjugates 4a, 4d, 4g, 4j, 4m, and 4p are promising antitubercular agents.
- 1 July 2016
- Published by Elsevier in Chinese Chemical Letters
- Vol. 27 (7) , 1058-1063
1,2,3-Triazole tethered acetophenones: Synthesis, bioevaluation and molecular docking study
- 1 July 2016
- Published by Elsevier in Chinese Chemical Letters
- Vol. 27 (7) , 1058-1063
1,2,3-Triazole tethered acetophenones: Synthesis, bioevaluation and molecular docking study
- 1 May 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (9) , 2278-2283
Novel tetrazoloquinoline–rhodanine conjugates: Highly efficient synthesis and biological evaluation
- 1 May 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (9) , 2278-2283
Novel tetrazoloquinoline–rhodanine conjugates: Highly efficient synthesis and biological evaluation
- 1 April 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (7) , 1704-1708
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents
- 1 April 2016
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (7) , 1704-1708
Facile synthesis of 1,3-thiazolidin-4-ones as antitubercular agents
- 29 February 2016
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 42 (8) , 6607-6626
[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity
- 29 February 2016
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 42 (8) , 6607-6626
[Et3NH][HSO4] catalyzed efficient synthesis of 5-arylidene-rhodanine conjugates and their antitubercular activity
- 19 February 2016
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25 (4) , 790-804
Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents
- 19 February 2016
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25 (4) , 790-804
Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents